Capitalizing on Cancer Replication Stress by Preventing PAR Chain Turnover: A New Type of Synthetic Lethality

Cancer Cell - United States
doi 10.1016/j.ccell.2019.03.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Capitalizing on Cancer Replication Stress by Preventing PAR Chain Turnover: A New Type of Synthetic Lethality

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

Immunotherapy Exposes Cancer Stem Cell Resistance and a New Synthetic Lethality

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Synthetic Lethality as a Targeted Approach to Advanced Prostate Cancer

2012English

E-Cadherin/Ros1 Inhibitor Synthetic Lethality in Breast Cancer

Cancer Discovery
Oncology
2018English

KEAP1-Dependent Synthetic Lethality Induced by AKT and TXNRD1 Inhibitors in Lung Cancer

Cancer Research
Cancer ResearchOncology
2013English

Cancer-Specific Synthetic Lethality Between ATR and CHK1 Kinase Activities

Cell Reports
BiochemistryGeneticsMolecular Biology
2016English

How Cancer Genomics Drives Cancer Biology: Does Synthetic Lethality Explain Mutually Exclusive Oncogenic Mutations?

Cold Spring Harbor Symposia on Quantitative Biology
BiochemistryGeneticsMolecular Biology
2016English

Synthetic Lethality in the Search for Novel Molecular Targets in Cancer Therapeutics

Juntendo Medical Journal
2019English

A New Type of Synthetic Fire Opal: Mexifire

Gems and Gemology
PetrologyGeochemistry
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy